Clinical Trials
7 trialsNCT06583395 2024-11-01
QUANTUM
VitaMed Research LLC
Enrolling by invitation
NCT03016013 2024-09-26
A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects with Inadequate Response to MTX Due to Treat Moderate and Severe Rheumatoid Arthritis.
RemeGen Co., Ltd.
Phase 3 Completed
NCT03120949 2023-10-12
CREDO 4
R-Pharm
Phase 3 Completed
NCT02822495 2023-06-15
Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies
Atara Biotherapeutics
No longer available
NCT02882087 2019-04-03
A Study of the Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Inadequate Response to TNF-α Antagonists Due to Treat Moderate and Severe Rheumatoid Arthritis
RemeGen Co., Ltd.
Phase 2 Terminated
NCT00440817 2014-04-10
An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease.
Centocor Ortho Biotech Services, L.L.C.
Completed
NCT00224562 2005-10-26
The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists
Assistance Publique - Hôpitaux de Paris
Unknown